NANO Nuclear Energy enters the week of May 20 with bears firmly in control: short interest has hit a fresh multi-week high even as the stock has shed nearly a fifth of its value, creating the classic tension between mounting bearish conviction and an increasingly oversold price.
The short-side story is the dominant one right now. Short interest climbed to 24.9% of the free float on May 19 — up from 21.3% just two weeks ago and near the highest level seen outside of the early-April spike above 26%. That month-on-month rise of roughly 22% in shares short shows systematic accumulation, not noise. The borrow market confirms the demand: availability has tightened sharply to just 8.8%, down from around 19.6% only a week ago, meaning fewer than one share remains available to borrow for every ten already lent out. The ORTEX short score of 75.1 ranks NNE in roughly the 2nd percentile of all stocks by that metric — an extreme reading that has held consistently above 74 for the past two weeks.
Borrow cost tells a slightly different story, and it is worth naming the contrast. Despite rising short interest, the cost to borrow has actually fallen — from nearly 6% in late April to 3.96% today. That decline suggests the squeeze on available supply is not yet translating into a frenzied grab for borrows; shorts are adding positions but not at panic pricing. The put/call ratio of 0.45 is roughly in line with its 20-day average of 0.44, confirming that options traders are not adding extra defensive hedges on top of the short book. This is a short-driven story, not a broad panic.
The Street's view is divided and, on the most recent analyst data available (all changes from mid-2025 or earlier), somewhat stale. HC Wainwright has reiterated Buy with a $50 target through August 2025. Ladenburg Thalmann flipped from Buy to Sell in August 2025, cutting its target from $51 to $9. With the stock trading around $22, the gap between the most bullish and most bearish targets is extraordinary — bulls price in a near-doubling while the one sell-side bear sees further downside. The consensus mean target of $47.50 implies over 100% upside from current levels, but that figure is driven by just two buy-rated analysts and should be treated with caution given how dated some of these marks are. Valuation multiples are negative throughout — NNE is a pre-revenue story, so the PE and EV/EBITDA readings are not meaningful anchors. Forward EPS momentum ranks in the 5th percentile over 90 days, reflecting worsening near-term estimates for a company still in development mode.
Insider activity adds context rather than a clear signal. The largest filing on record is a cluster of sales by the principal investor I Financial Ventures Group and CEO James Walker in late January, totalling roughly $10 million worth of stock at prices between $30 and $35 — well above where the stock trades today. Net insider activity over the past 90 days shows net selling of around $56 million in value. There has been no buying activity on record in the recent data. That pattern — insiders reducing near the highs while shorts pile in as the stock retreats — is the backdrop the market is repricing around. Among peers, SMR fell 16% on the week, closely tracking NNE's decline, while ENVX dropped 21% — suggesting the broader speculative clean-energy and small-cap nuclear space is under concurrent pressure rather than NNE seeing isolated flows.
The next confirmed earnings event is August 13. Between now and then, the key variables to watch are whether availability continues to tighten toward zero — the 52-week low was exactly zero — and whether the ongoing share-count build in short interest stalls or accelerates as the stock approaches its post-correction lows.
See the live data behind this article on ORTEX.
Open NNE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
